Cancer News and Research

Latest Cancer News and Research

Molecule called Smad7 may open doors to future treatments in pancreatic and other forms of cancer

Making new strides in their ongoing effort to understand mechanisms behind the relentless growth of cancer cells, researchers at Dartmouth Medical School have found a promising key that may open doors to future treatments in pancreatic and other forms of cancer.

9 Jun 2005

Exercise and weight control reduces odds of developing breast cancer

Women who exercise more and keep their weight under control may dramatically reduce their odds of developing breast cancer, a population-based study by a team of investigators at Meharry Medical College and the Vanderbilt-Ingram Cancer Center suggests.

9 Jun 2005

Concern for smokers who don't understand nicotine

Medical experts warned today that thousands of smokers are jeopardising their chances of quitting successfully. New data presented at the UK National Smoking Cessation Conference (UKNSCC) shows that misconceptions about the role of nicotine are preventing smokers from quitting using nicotine replacement therapies (NRT) that actually increase the chances of quitting for good.

9 Jun 2005

12-year-old cancer victim taken into care after parents block treatment on religious grounds

State Child Protective Services in Texas are going to court on June 15 to try to get custody of a 12-year-old girl suffering from advanced Hodgkin's disease.

9 Jun 2005

Patients with cancer of the esophagus benefit from new technique developed by OHSU surgeons

Surgeons at the Oregon Health & Science University Digestive Health Center have developed a new technique that makes feasible and safe a potentially lifesaving and noninvasive surgical procedure known as laparoscopic esophagectomy.

9 Jun 2005

Pillcam enables Jefferson Physicians to diagnose diseases of esophagus without using endoscope

Most digestive disease specialists will tell you that patients would rather suffer from heartburn and other diseases of the upper GI system than undergo a very effective but also potentially uncomfortable and relatively invasive procedure to diagnose their problem.

9 Jun 2005

Study of glial cells in the roundworm C. elegans may provide insight into a variety of human brain diseases

The key to understanding our brains may lie within a one-millimeter long worm, new research from Rockefeller University indicates. Reporting in the June issue of Developmental Cell, Shai Shaham, Ph.D., and graduate student Elliot Perens use the roundworm, C. elegans, to investigate the mysterious glial cell, which makes up 90 percent of the human brain and, when it malfunctions, can contribute to diseases like Parkinson's disease and schizophrenia.

9 Jun 2005

Healthy neighborhoods for older adults subject of study

Doctors often advise their older patients to walk more to enhance their health, but what if the sidewalks are crumbling; if they don't know a neighbor who could serve as a walking partner to help them feel safe; or if there's nothing interesting to see outside of their homes?

9 Jun 2005

Doctors and patients think differently about clinical trials

A survey of patients and physicians regarding clinical trials shows that doctors don't recognize the importance of side effects as a barrier for their patients in deciding about whether to undergo experimental therapy.

9 Jun 2005

Designed drug for combined hormone and chemotherapy treatment

The search for new drugs to fight cancer remains at the top of the to do list for pharmaceutical researchers. A recent variation is polymer chemotherapy agents, drugs that have been attached to a "backbone" of long chain molecules.

9 Jun 2005

Lorus Therapeutics receives patent allowance to protect novel anticancer drug

Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.

9 Jun 2005

MabThera highly effective in treating rheumatoid arthritis

Results from the DANCER study presented today revealed that MabThera significantly improves symptoms in heavily treated patients who are affected by moderate-to-severe rheumatoid arthritis (RA), a painful and debilitating disease of the joints.

9 Jun 2005

Female gynecologists use more estrogen than the average woman

After studies appeared showing that treating menopausal complaints with estrogen entailed not wholly positive health effects, the prescription of such preparations declined.

9 Jun 2005

MicroRNAs play an important role in human cancer

Over the past few years, scientists have discovered that a new class of genetic regulators called "microRNAs" influences normal human growth and development. Now, researchers have found that microRNAs also play an important role in human cancer. The findings are published in today's issue of the journal Nature (June 9).

9 Jun 2005

New study shows tiny RNAs intimately associated with cancer

In discoveries that may open a new chapter in understanding and diagnosing cancer, Howard Hughes Medical Institute (HHMI) investigators and their colleagues have established that tiny microRNAs provide a novel genetic route to the initiation of some forms of cancer.

9 Jun 2005

Rituximab provides new hope for people with lupus

Rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria heard today (Thursday 9 June) that rituximab is the first drug in a quarter of a century that is making a real impact, and an alternative to previous standard treatments of high-dose steroids, and chemotherapy.

9 Jun 2005

Density of breast tissue can directly influence tumour development

New research suggests that there is a direct relationship between the density of breast tissue, and the risk of developing tumours in dense areas of the breast.

8 Jun 2005

Researchers link aberrant 'microRNA' expression to human cancer

8 Jun 2005

New understanding of microRNAs

Ribonucleic acid, or RNA, has long been thought to be important only to translate a gene's DNA into the proteins that are cells' workhorses. But new evidence shows that tiny bits of RNA not used to make proteins actually play central roles in normal biology and in the development of cancers.

8 Jun 2005

Novel targets found for the development of drugs to complement, or replace, statins

A team of investigators from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) and Harvard Medical School has uncovered novel targets for the development of drugs that would potentially complement, or replace, statins in treating heart disease.

8 Jun 2005